Developer docs
API playgroundTry for free, no card

Search company profiles

CellNetix Pathology & Laboratories

Full company profile

uuid0008eoc

Namestring
CellNetix Pathology & Laboratories
Legal namestring
CellNetix Pathology & Laboratories, LLC
Websiteurl
cellnetix.com
Company typeenum
Private
Founded yearint
2005
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersTukwila, United States
HQ citystring
Tukwila
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
anatomic pathology services, clinical laboratory testing, molecular pathology diagnostics, hematopathology diagnostics, women's health pathology
Industry5 codes
PRIMARYHLAFAMAA
Anatomic Pathology (Histopathology & Cytopathology)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLACAMAJ
Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Pathology Testing Services
TypeProfessional Services
Description

Professional pathology diagnostic services billed per CPT codes. Services include surgical pathology, molecular testing, cytology, immunohistochemistry, and flow cytometry. Multiple CPT codes may be billed for multiple biopsies, IHC stains, and flow markers.

cellnetix.com
2Laboratory Technical Services
TypeProfessional Services
Description

Technical component of laboratory testing including specimen processing, staining, and analysis

cellnetix.com
3Client Portal Services
TypeManaged Services
Description

Atlas web portal for ordering tests, viewing results, and supply requests for healthcare facilities

cellnetix.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Pricing details1 tier
1Standard Pathology Services
ModelOtherBilling cadencePay-as-you-go
Notes

Billed per CPT codes based on services rendered. Multiple specimens and tests result in multiple charges. Contact billing at 877-340-5884 for estimates.

cellnetix.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1Atlas Portal
Description

A web portal for physicians and healthcare staff to view patient results, order lab tests and supplies, and request courier pickups.

cellnetix.com
+1 more record
Core offering1 text field

CellNetix Pathology & Laboratories is a private regional pathology group headquartered in Seattle, Washington that delivers anatomic, clinical, molecular, hematopathology, and women's health diagnostic services through more than 60 board-certified pathologists covering 25+ medical subspecialties. The company supports hospitals, clinics, and physician practices across Washington, Oregon, Idaho, Alaska, and Arizona with routine and specialized diagnostic testing, advanced molecular assays (including SymGene NGS cancer panels), and digital pathology workflow tools such as the Atlas client portal.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Precise diagnoses through peer-to-peer collaboration across 25+ subspecialties
+3 more records
Product overview1 text field

CellNetix Pathology & Laboratories operates as a comprehensive pathology services provider offering a unified portfolio of diagnostic services. The core offerings include Anatomic Pathology Services and Clinical Pathology Services across 25+ subspecialties, supported by 60+ board-certified pathologists. The Molecular Pathology division provides specialized testing through the SymGene79 NGS Cancer Panel and related focus panels. The Atlas Portal serves as the primary digital interface for healthcare professionals to access results, order tests, and manage supplies. The company also provides specialized services in hematopathology and women's health, with a focus on cancer diagnostics and personalized medicine through genetic testing.

Product and service6 records
1Anatomic Pathology Services
CategoryAnatomic Pathology
Description

Subspecialty anatomic pathology interpretation of biopsy, surgical, and cytology specimens, delivered by 60+ board-certified pathologists across 25+ subspecialties to hospitals, clinics, and physician practices.

2Clinical Pathology / Laboratory Testing
CategoryClinical Pathology
Description

Clinical laboratory testing service that supports routine and specialized clinical diagnostics, run through the Sunquest Mitogen laboratory information system for referring healthcare providers.

3Molecular Pathology (SymGene NGS Cancer Panels)
CategoryMolecular Pathology
Description

In-house molecular oncology diagnostic testing using next-generation sequencing panels (SymGene79 NGS Cancer Panel, SymGene Focus panels, and SymGene Myeloid Panel) to support cancer and myeloid disease workups for referring oncologists and hospitals.

4Hematopathology Services
CategoryHematopathology
Description

Specialized hematopathology diagnostic service covering blood, bone marrow, and lymph node specimens, including molecular myeloid workups, for referring hematologists, oncologists, and hospitals.

5Women's Health Pathology
CategoryWomen's Health Pathology
Description

Specialized women's health pathology service covering gynecologic cytology, breast, and related diagnostic interpretation, designed for OB/GYN and women's health practices and the hospitals that support them.

6Atlas Portal
CategoryClient and Patient Portal
Description

Online portal that gives referring clinicians and patients electronic access to order entry, result retrieval, and specimen logistics for CellNetix pathology and laboratory services.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-12-06
Description

CellNetix partnered with Proscia, a leading digital and computational pathology solutions provider, to digitize its pathology practice. The partnership involves digitizing 1 million glass slides per year using Proscia's digital pathology platform. This enables CellNetix to achieve greater workflow flexibility, productivity gains, streamlined collaboration among distributed pathologists, and positions the company to leverage AI for future insights. CellNetix was presented an award from Proscia for advancing AI in Clinical Practice.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2020-07-07
Description

Collaboration to validate SpIntellx's HistoMapr-Breast platform for spatial analytics and explainable AI (xAI) in digital pathology. This platform is designed to triage cases to subspecialists, perform retroactive quality assurance, reduce intra- and inter-pathologist discordance, provide transparent AI guidance, and facilitate standardized reporting. Dr. Dominique Coco serves as lead project pathologist.

3Sunquest Information Systems
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2017-11-17
Description

Sunquest partnered with N-of-One and CellNetix to integrate N-of-One's clinical interpretation solutions into Sunquest Mitogen LIMS software. CellNetix served as the first customer ship (FCS) for this integration. The partnership streamlines delivery of time-critical genetic reports with clinical interpretation for next generation sequencing (NGS) panels, supporting precision medicine initiatives.

cellnetix.com
4N-of-One
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2017-11-17
Description

N-of-One provides clinical interpretation for molecular diagnostics in oncology. Through the Sunquest partnership, N-of-One's content enables creation of reports including biomarker-driven therapies, clinical trials, genetic variant interpretation, and treatment identification. CellNetix was the first customer ship for this integration.

cellnetix.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest U.S. clinical laboratory network offering anatomic pathology, molecular diagnostics, and hospital reference lab services nationwide. Comparable to CellNetix as a full-service diagnostic provider with hospital/physician channels, though much larger and more diversified.

TypeBroad incumbent
Description

National clinical and anatomic pathology reference lab serving hospitals, physicians, and biopharma. Directly comparable to CellNetix in anatomic and molecular pathology offerings, with substantially broader geographic reach and biopharma central lab services.

TypeDirect peer
Description

Private, physician-led anatomic and clinical pathology practice serving hospitals, clinics, and physicians across the Southeast and beyond. Closely comparable to CellNetix as a similarly scaled independent pathology group with subspecialty coverage and molecular capabilities.

TypeBroad incumbent
Description

Nonprofit reference laboratory affiliated with the University of Utah offering esoteric testing, anatomic pathology, and molecular diagnostics. Comparable to CellNetix in providing specialty reference testing and academic-grade subspecialty expertise to hospitals.

TypeBroad incumbent
Description

Subsidiary of Sonic Healthcare operating multiple regional pathology and laboratory brands across the U.S. Comparable to CellNetix as a multi-regional anatomic and clinical pathology provider with subspecialty focus and hospital medical directorships.

TypeDirect peer
Description

Specialized oncology-focused clinical laboratory providing molecular and anatomic pathology services to community hospitals and oncologists. Comparable to CellNetix in NGS-based oncology profiling and hospital-channel molecular diagnostics.

TypeEmerging player
Description

Molecular diagnostics and AI-driven precision medicine company offering comprehensive tumor profiling. Comparable to CellNetix as an NGS-based oncology testing provider, though more focused on biopharma and advanced molecular profiling than routine anatomic pathology.

TypeEmerging player
Description

Liquid biopsy and oncology molecular diagnostics company. Partial overlap with CellNetix's SymGene79 NGS panel as a molecular oncology testing competitor, though differentiated by blood-based versus tissue-based profiling.

TypeBroad incumbent
Description

Comprehensive genomic profiling for oncology within Roche. Comparable to CellNetix as a tumor NGS provider serving oncologists and biopharma, but with broader national reach and larger clinical evidence base.

TypeOthers
Description

Digital and computational pathology platform provider and direct technology partner of CellNetix. Comparable not as a competitor but as the platform underpinning CellNetix's digital pathology transformation, illustrating the broader category of digital pathology vendors shaping the space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CellNetix Pathology & Laboratories

CellNetix Pathology & Laboratories firmographics

Firmographics
Name
CellNetix Pathology & Laboratories
Legal name
CellNetix Pathology & Laboratories, LLC
Website
https://cellnetix.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
251–500 employees
Ownership category
akta.pro rank

CellNetix Pathology & Laboratories industry classification

Industry
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAFAMAA
Anatomic Pathology (Histopathology & Cytopathology)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLACAMAJ
Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)

Keywords

  • Anatomic pathology services
  • Clinical laboratory testing
  • Molecular pathology diagnostics
  • Hematopathology diagnostics
  • Women's health pathology

Where CellNetix Pathology & Laboratories is headquartered

Location

Headquarters

HQ city
Tukwila
HQ country
United States
HQ region
North America

Offices9 records

Markets served

CellNetix Pathology & Laboratories business model

Business model
GTM type
B2B
Offering type
Services

Revenue model

  1. Pathology Testing Services: Professional pathology diagnostic services billed per CPT codes. Services include surgical pathology, molecular testing, cytology, immunohistochemistry, and flow cytometry. Multiple CPT codes may be billed for multiple biopsies, IHC stains, and flow markers.
  2. Laboratory Technical Services: Technical component of laboratory testing including specimen processing, staining, and analysis
  3. Client Portal Services: Atlas web portal for ordering tests, viewing results, and supply requests for healthcare facilities

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goStandard Pathology Services

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

CellNetix Pathology & Laboratories product offering

Product offering

Core offering

CellNetix Pathology & Laboratories is a private regional pathology group headquartered in Seattle, Washington that delivers anatomic, clinical, molecular, hematopathology, and women's health diagnostic services through more than 60 board-certified pathologists covering 25+ medical subspecialties. The company supports hospitals, clinics, and physician practices across Washington, Oregon, Idaho, Alaska, and Arizona with routine and specialized diagnostic testing, advanced molecular assays (including SymGene NGS cancer panels), and digital pathology workflow tools such as the Atlas client portal.

Product overview

CellNetix Pathology & Laboratories operates as a comprehensive pathology services provider offering a unified portfolio of diagnostic services. The core offerings include Anatomic Pathology Services and Clinical Pathology Services across 25+ subspecialties, supported by 60+ board-certified pathologists. The Molecular Pathology division provides specialized testing through the SymGene79 NGS Cancer Panel and related focus panels. The Atlas Portal serves as the primary digital interface for healthcare professionals to access results, order tests, and manage supplies. The company also provides specialized services in hematopathology and women's health, with a focus on cancer diagnostics and personalized medicine through genetic testing.

Differentiator

Problem solved

Functional benefit

Brands

  • Atlas Portal: A web portal for physicians and healthcare staff to view patient results, order lab tests and supplies, and request courier pickups.
  • SymGene79™ NGS Cancer Panel

Products and services

  • Anatomic Pathology Services Subspecialty anatomic pathology interpretation of biopsy, surgical, and cytology specimens, delivered by 60+ board-certified pathologists across 25+ subspecialties to hospitals, clinics, and physician practices.
  • Clinical Pathology / Laboratory Testing Clinical laboratory testing service that supports routine and specialized clinical diagnostics, run through the Sunquest Mitogen laboratory information system for referring healthcare providers.
  • Molecular Pathology (SymGene NGS Cancer Panels) In-house molecular oncology diagnostic testing using next-generation sequencing panels (SymGene79 NGS Cancer Panel, SymGene Focus panels, and SymGene Myeloid Panel) to support cancer and myeloid disease workups for referring oncologists and hospitals.
  • Hematopathology Services Specialized hematopathology diagnostic service covering blood, bone marrow, and lymph node specimens, including molecular myeloid workups, for referring hematologists, oncologists, and hospitals.
  • Women's Health Pathology Specialized women's health pathology service covering gynecologic cytology, breast, and related diagnostic interpretation, designed for OB/GYN and women's health practices and the hospitals that support them.
  • Atlas Portal Online portal that gives referring clinicians and patients electronic access to order entry, result retrieval, and specimen logistics for CellNetix pathology and laboratory services.

Quantifiable outcome

  • Precise diagnoses through peer-to-peer collaboration across 25+ subspecialties
  • +3 more outcomes

Companies that use CellNetix Pathology & Laboratories

Customer profile

Named customers2 records

Segments3 records

CellNetix Pathology & Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature5 records

CellNetix Pathology & Laboratories partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and strategic.

  • ProsciacoreTechnology or Integration · 6 December 2023CellNetix partnered with Proscia, a leading digital and computational pathology solutions provider, to digitize its pathology practice. The partnership involves digitizing 1 million glass slides per year using Proscia's digital pathology platform. This enables CellNetix to achieve greater workflow flexibility, productivity gains, streamlined collaboration among distributed pathologists, and positions the company to leverage AI for future insights. CellNetix was presented an award from Proscia for advancing AI in Clinical Practice.
  • SpIntellxstrategicStrategic or Co-development Partner · 7 July 2020Collaboration to validate SpIntellx's HistoMapr-Breast platform for spatial analytics and explainable AI (xAI) in digital pathology. This platform is designed to triage cases to subspecialists, perform retroactive quality assurance, reduce intra- and inter-pathologist discordance, provide transparent AI guidance, and facilitate standardized reporting. Dr. Dominique Coco serves as lead project pathologist.
  • Sunquest Information SystemscoreTechnology or Integration · 17 November 2017Sunquest partnered with N-of-One and CellNetix to integrate N-of-One's clinical interpretation solutions into Sunquest Mitogen LIMS software. CellNetix served as the first customer ship (FCS) for this integration. The partnership streamlines delivery of time-critical genetic reports with clinical interpretation for next generation sequencing (NGS) panels, supporting precision medicine initiatives.
  • N-of-OnecoreTechnology or Integration · 17 November 2017N-of-One provides clinical interpretation for molecular diagnostics in oncology. Through the Sunquest partnership, N-of-One's content enables creation of reports including biomarker-driven therapies, clinical trials, genetic variant interpretation, and treatment identification. CellNetix was the first customer ship for this integration.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

CellNetix Pathology & Laboratories competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: Largest U.S. clinical laboratory network offering anatomic pathology, molecular diagnostics, and hospital reference lab services nationwide. Comparable to CellNetix as a full-service diagnostic provider with hospital/physician channels, though much larger and more diversified.
  • Laboratory Corporation of America (Labcorp): National clinical and anatomic pathology reference lab serving hospitals, physicians, and biopharma. Directly comparable to CellNetix in anatomic and molecular pathology offerings, with substantially broader geographic reach and biopharma central lab services.
  • ARUP Laboratories: Nonprofit reference laboratory affiliated with the University of Utah offering esoteric testing, anatomic pathology, and molecular diagnostics. Comparable to CellNetix in providing specialty reference testing and academic-grade subspecialty expertise to hospitals.
  • Sonic Healthcare USA: Subsidiary of Sonic Healthcare operating multiple regional pathology and laboratory brands across the U.S. Comparable to CellNetix as a multi-regional anatomic and clinical pathology provider with subspecialty focus and hospital medical directorships.
  • Foundation Medicine (Roche): Comprehensive genomic profiling for oncology within Roche. Comparable to CellNetix as a tumor NGS provider serving oncologists and biopharma, but with broader national reach and larger clinical evidence base.

Direct peers

  • PathGroup: Private, physician-led anatomic and clinical pathology practice serving hospitals, clinics, and physicians across the Southeast and beyond. Closely comparable to CellNetix as a similarly scaled independent pathology group with subspecialty coverage and molecular capabilities.
  • NeoGenomics Laboratories: Specialized oncology-focused clinical laboratory providing molecular and anatomic pathology services to community hospitals and oncologists. Comparable to CellNetix in NGS-based oncology profiling and hospital-channel molecular diagnostics.

Emerging players

  • Caris Life Sciences: Molecular diagnostics and AI-driven precision medicine company offering comprehensive tumor profiling. Comparable to CellNetix as an NGS-based oncology testing provider, though more focused on biopharma and advanced molecular profiling than routine anatomic pathology.
  • Guardant Health: Liquid biopsy and oncology molecular diagnostics company. Partial overlap with CellNetix's SymGene79 NGS panel as a molecular oncology testing competitor, though differentiated by blood-based versus tissue-based profiling.

Others

  • Proscia: Digital and computational pathology platform provider and direct technology partner of CellNetix. Comparable not as a competitor but as the platform underpinning CellNetix's digital pathology transformation, illustrating the broader category of digital pathology vendors shaping the space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

CellNetix Pathology & Laboratories social profiles

Digital presence

CellNetix Pathology & Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CellNetix Pathology & Laboratories leadership team

Management profile

Number of profiles

CellNetix Pathology & Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CellNetix Pathology & Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CellNetix Pathology & Laboratories

What does CellNetix Pathology & Laboratories do?

CellNetix Pathology & Laboratories is a private regional pathology group headquartered in Seattle, Washington that delivers anatomic, clinical, molecular, hematopathology, and women's health diagnostic services through more than 60 board-certified pathologists covering 25+ medical subspecialties. The company supports hospitals, clinics, and physician practices across Washington, Oregon, Idaho, Alaska, and Arizona with routine and specialized diagnostic testing, advanced molecular assays (including SymGene NGS cancer panels), and digital pathology workflow tools such as the Atlas client portal.

Is CellNetix Pathology & Laboratories a public or private company?

CellNetix Pathology & Laboratories is a private company. It is currently operating.

When was CellNetix Pathology & Laboratories founded?

CellNetix Pathology & Laboratories was founded in 2005. It employs 251 to 500 people.

Where is CellNetix Pathology & Laboratories based?

CellNetix Pathology & Laboratories is headquartered in Tukwila, United States, in the North America region.

How does CellNetix Pathology & Laboratories make money?

Three revenue lines are on record. Pathology Testing Services are the primary driver. The others are laboratory Technical Services and client Portal Services.

Who are CellNetix Pathology & Laboratories's main competitors?

Broad incumbents on record are Quest Diagnostics, Laboratory Corporation of America (Labcorp), ARUP Laboratories, Sonic Healthcare USA and Foundation Medicine (Roche). Direct peers are PathGroup and NeoGenomics Laboratories. Emerging players are Caris Life Sciences and Guardant Health. Proscia is listed as an others.

Does CellNetix Pathology & Laboratories have an API?

No public API is recorded for CellNetix Pathology & Laboratories.

What industry is CellNetix Pathology & Laboratories in?

Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology), with a secondary code of HLAFAMAE, Molecular Diagnostics & Genomics Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals